Last 1.42 MYR
Change Today 0.00 / 0.00%
Volume 12.0K
YSP On Other Exchanges
Symbol
Exchange
OTC US
As of 8:31 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

y.s.p.southeast asia holding (YSP) Snapshot

Open
1.42
Previous Close
1.42
Day High
1.42
Day Low
1.42
52 Week High
05/14/14 - 1.85
52 Week Low
01/27/14 - 1.25
Market Cap
188.9M
Average Volume 10 Days
10.5K
EPS TTM
0.11
Shares Outstanding
133.0M
EX-Date
07/16/14
P/E TM
12.9x
Dividend
0.07
Dividend Yield
4.58%
Current Stock Chart for Y.S.P.SOUTHEAST ASIA HOLDING (YSP)

Related News

No related news articles were found.

y.s.p.southeast asia holding (YSP) Related Businessweek News

No Related Businessweek News Found

y.s.p.southeast asia holding (YSP) Details

Y.S.P. Southeast Asia Holding Berhad, an investment holding company, manufactures, imports, exports, and trades various kinds of pharmaceutical products. The company offers its products in gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. It provides prescription products comprising antibacterial and analgesic lozenges, antibiotics, antidiarrheals, antiemetics, antihistamines, antihistamine plus decongestant, antiprotozoal and antiamoebic, antispasmodics, antispasmodics with psycholeptics, drugs for gout therapy, H2-antagonists, antifibrinolytics, nootropics and neurotonics, non-steroidal anti-inflammatory, antipyretics and analgesics, peripheral vasodilators, proton pump inhibitors, and skeletal muscle relaxants; antiasthmatic, anti-diabetic, antifungal, lipid regulating, antihypertensive, antitussive, antiviral, and chemotherapeutics agents, as well as and steroidal, anorectal, and topical preparations. The company also offers non-prescription products, such as anthelmintic agents, antacids, anti-inflammatory enzymes, antipyretics and analgesics, anti-platelet, carminatives, digestive enzymes, expectorants/mucolytic agents, haemorrhoidal preparations, and laxatives; and traditional medicines. In addition, it provides veterinary pharmaceutical products for aquatic and live stock, including anthelmintics, antibiotics, antifungals, anticoccidial agent, antipyretics and analgesics, disinfectants, electrolytes, hematopoietic nutrients, herbal extracts, hormones preparations, probiotics, immune enhancers, vitamins and minerals supplements, antimicrobial, larval feeds, and minerals. Further, the company offers disposables, medical devices, test kits, first aids, medical aids, and insect repellents. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, and internationally. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Founded in 1987

y.s.p.southeast asia holding (YSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

y.s.p.southeast asia holding (YSP) Key Developments

Y.S.P. Southeast Asia Holding Berhad Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

YSP Southeast Asia Holdings Bhd reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue of MYR 46.1 million compared to MYR 46.6 million last year. The decrease was mainly due to lower demand from domestic market. Profit before tax was MYR 2.3 million compared to MYR 5.0 million a year ago. Profit attributable to owners of the company was MYR 0.964 million or 0.72 sen per basic share compared to profit attributable to owners of the company of MYR 3.5 million or 2.64 sen per basic Share a year ago. Result from operating activities was MYR 2.3 million compared to MYR 5.2 million a year ago. Lower profit before tax was due lower revenue recorded during the quarter and also due to higher foreign exchange loss recognised for the current quarter under review. For the six months, the company reported profit attributable to owners of the company of MYR 6.7 million or 4.82 sen per basic share compared to profit attributable to owners of the company of MYR 8 million or 5.98 sen per basic share a year ago. Revenue was MYR 97.5 million compared to MYR 95.4 million a year ago. Result from operating activities was MYR 10.4 million compared to MYR 11.6 million a year ago. Profit before tax was MYR 10.3 million compared to MYR 11.1 million a year ago. Net cash generated from operating activities was MYR 6.4 million and purchase of property, plant and equipment was MYR 4.3 million compared to MYR 19.7 million and purchase of property, plant and equipment of MYR 2.3 million a year ago. The decrease in profit before tax was due to higher selling and distribution expenses and foreign exchange loss for the current period under review.

Y.S.P. Southeast Asia Holding Mulls Acquisitions

Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) is looking for acquisitions. Managing Director, Datuk Lee Fang Hsin said that the company is looking at the merger and acquisition route for growth and has identified several potential international and local companies. The official, however, declined to elaborate, saying that they are still at the negotiation stage. He said, “We plan to merge [with potential companies] to diversify our product range. However, any acquisitions of companies will be in the same [pharmaceutical] industry. For example, we acquired Sun Ten Pharmaceutical Co Ltd, a manufacturer of herbal extracts from Taiwan, back in 2008 to diversify into traditional herbal products.”

Y.S.P. Southeast Asia Holding Berhad Announces First and Final Single Tier Dividend for the Financial Year Ended December 31, 2013, Payable on August 15, 2014

Y.S.P. Southeast Asia Holding Berhad announced the first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each for the financial year ended December 31, 2013 ad the payment date is on August 15, 2014 and the ex-dividend date is on July 16, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YSP:MK 1.42 MYR 0.00

YSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for YSP.
View Industry Companies
 

Industry Analysis

YSP

Industry Average

Valuation YSP Industry Range
Price/Earnings 12.3x
Price/Sales 0.9x
Price/Book 0.8x
Price/Cash Flow 12.3x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Y.S.P.SOUTHEAST ASIA HOLDING, please visit www.yspsah.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.